D-1089-2017 Class III Terminated

Recalled by Akorn Inc — Lake Forest, IL

FDA drug recall D-1089-2017 was initiated by Akorn Inc on Jul 12, 2017 and is designated Class III. Reason for recall: Crystallization with subpotent out of specification assay results for chlorhexidine. The recall status is terminated (terminated Jun 19, 2018). Affected quantity: 40,978 unit dose cups.

Recall details

Product Type
Drugs
Report Date
Aug 23, 2017
Initiation Date
Jul 12, 2017
Termination Date
Jun 19, 2018
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
40,978 unit dose cups

Product description

Halyard 24-Hour Oral Care Kit q2, contains 2x15 mL Unit Dose Cups 0.12% Chlorhexidine Gluconate Oral Rinse. Manufactured by Halyard Health Inc., 5405 Windward Parkway, Alpharetta, GA 30004. Distributed by Halyard Sales, LLC Alpharetta, GA 30004. REF # 97012

Reason for recall

Crystallization with subpotent out of specification assay results for chlorhexidine.

Distribution pattern

Nationwide in the USA

Code information

Lots: 0202623109, 0202623110, 0202623111, 0202630207, 0202630208, 0202630209, EXP 06-2018; 0202642227, 0202642228, 0202647413, 0202647414, 0202653433, 0202653434, EXP 07-2018.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1089-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1089-2017. Report a data issue: hello@regdatalab.com.